Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Chevron Corporation
Street 1: 6001 Bollinger Canyon Rd
Street 2:
City: San Ramon
Province: California
Post Code: 94583
Country: United States of America
Phone: +1 925 842 0879
Email: globalpublichealth@chevron.com
Web Site: http://www.chevron.com

Focal Point Contact Information

Salutation: Mr.
First Name: Ernesto
Last Name: De La Torre
Title: Team Lead, Global Public Health
Email: edelatorre@chevron.com
Phone: 9258420879

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: David
Last Name: McMurry
Title: Manager, Global Public Health
Email: bounced
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Chevron is one of the world's leading integrated energy companies, with subsidiaries that conduct business around the globe. Our success is driven by the ingenuity and commitment of approximately 62,000 employees who operate across the energy spectrum. We explore for, produce and transport crude oil and natural gas; refine, market and distribute transportation fuels and other energy products; manufacture and sell petrochemical products; generate power and produce geothermal energy; provide energy-efficiency solutions; and develop and commercialize the energy resources of the future, including biofuels and other renewables.
HIV/AIDS, Malaria, and Tuberculosis – At Chevron attention to these three diseases has been combined into a single Global Public Health framework. Although serious diseases they are preventable and treatable. We hope to minimize workforce and family risk while utilizing proven best practices and optimizing internal and external resources.
Chevron’s tuberculosis program is targeted at workforce and families located in countries with high TB prevalence and in facilities or worksites that may increase TB risk. The education and awareness materials are available to all employees across the globe.
The purpose of the tuberculosis program is to: Improve awareness of tuberculosis among the workforce and families, prevent tuberculosis cases in high-risk populations, minimize the serious outcomes from all tuberculosis cases through early diagnosis and effective treatment, and to ensure a consistent approach to tuberculosis prevention and treatment across Chevron especially in high impact locations or targeted countries.
In 2009, Chevron deployed a situational analysis for regions with high TB prevalence or worksites with high risk for TB exposure. Data gathered from the situation analysis was used to develop our workplace Tuberculosis awareness training. The TB training is available in computer based and instructor lead versions and is approximately 30 min length. Non-brande
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 11 - 25
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? $25,000-$100,000
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We provide health and medical care to 60,000 employees and another 200,000 dependents and contractors across the globe. This care includes TB treatment and prevention education.

Additionally we partner with NGO's, governments and multilateral funding agencies to fight TB and increase prevention and awareness education in the countries and communities where we operate.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: South East Asian
Which countries do you do operate in:
(This includes countries you are conducting activities in)
France
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Honduras
India
Indonesia
Ireland
Italy
Jamaica
Japan
Kazakhstan
Kuwait
Lao People's Democratic Republic
Malawi
Malaysia
Mauritius
Mexico
Mozambique
Myanmar
Namibia
Netherlands
New Zealand
Nicaragua
Nigeria
Norway
Pakistan
Panama
Philippines
Poland
Qatar
Russian Federation
Saudi Arabia
Singapore
South Africa
Spain
Sri Lanka
Suriname
Swaziland
Sweden
Thailand
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United States of America
Uzbekistan
Venezuela
Viet Nam
Zambia
Zimbabwe

Specializations

Advocacy
Delivery of health services and care
Funding, including innovative and optimized approach to funding TB Care
Technical Assistance

Specializations in Countries

Advocacy Nigeria
Advocacy Philippines
Delivery of health services and care Nigeria
Delivery of health services and care Philippines
Funding, including innovative and optimized approach to funding TB Care Nigeria
Funding, including innovative and optimized approach to funding TB Care Philippines

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Ongoing TB awareness communication in Manila, PI. Our targeted audience is the transport sector. We are working throuhg our CalTex gas stations to increase TB awareness and drive people towards local DOTS clinics.

Declaration

Declaration of interests:
Chevron is a corporate champion and funder of the Global Fund and has also donated funds directly to the Stop TB Partnership.

Application date: July 9, 2010
Last updated: December 12, 2017